Kunming Pharmaceutical Group announced that the company and its subsidiaries plan to develop non-recourse accounts receivable factoring business with China Resources Commercial Factoring, with a total factoring financing amount of no more than 200 million yuan. The application period for factoring business is 3 years from the date of review and approval by the company's shareholders' meeting, and the period for individual factoring business shall not exceed 1 year. This transaction constitutes a related transaction, does not constitute a major asset restructuring, and still needs to be submitted to the company's shareholders' meeting for review and approval before implementation.

Kunming Pharmaceutical Group announced that the company and its subsidiaries plan to develop non-recourse accounts receivable factoring business with China Resources Commercial Factoring, with a total factoring financing amount of no more than 200 million yuan. The application period for factoring business is 3 years from the date of review and approval by the company's shareholders' meeting, and the period for individual factoring business shall not exceed 1 year. This transaction constitutes a related transaction, does not constitute a major asset restructuring, and still needs to be submitted to the company's shareholders' meeting for review and approval before implementation.